A secondary bile acid from microbiota metabolism attenuates ileitis and bile acid reduction in subclinical necrotic enteritis in chickens

被引:22
|
作者
Bansal, Mohit [1 ]
Fu, Ying [1 ,2 ]
Alrubaye, Bilal [1 ,2 ]
Abraha, Mussie [1 ]
Almansour, Ayidh [1 ,2 ]
Gupta, Anamika [1 ]
Liyanage, Rohana [3 ]
Wang, Hong [1 ]
Hargis, Billy [1 ]
Sun, Xiaolun [1 ,2 ,3 ]
机构
[1] Univ Arkansas, Ctr Excellence Poultry Sci, 1260 W Maple St O409, Fayetteville, AR 72701 USA
[2] Univ Arkansas, CEMB, Fayetteville, AR 72701 USA
[3] Univ Arkansas, Dept Chem, Fayetteville, AR 72701 USA
基金
美国食品与农业研究所;
关键词
Bile acid; Chicken; Clostridium perfringens; Deoxycholic acid; Intestinal inflammation; Necrotic enteritis; CLOSTRIDIUM-PERFRINGENS STRAINS; NEGATIVE FEEDBACK-REGULATION; BROILER-CHICKENS; MALABSORPTION; INFECTIONS; PATHOLOGY;
D O I
10.1186/s40104-020-00441-6
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Background Clostridium perfringens-induced chicken necrotic enteritis (NE) is responsible for substantial economic losses worldwide annually. Recently, as a result of antibiotic growth promoter prohibition, the prevalence of NE in chickens has reemerged. This study was aimed to reduce NE through titrating dietary deoxycholic acid (DCA) as an effective antimicrobial alternative. Materials and methods Day-old broiler chicks were assigned to six groups and fed diets supplemented with 0 (basal diet), 0.8, 1.0 and 1.5 g/kg (on top of basal diet) DCA. The birds were challenged with Eimeria maxima (20,000 oocysts/bird) at d 18 and C. perfringens (10(9) CFU/bird per day) at d 23, 24, and 25 to induce NE. The birds were sacrificed at d 26 when ileal tissue and digesta were collected for analyzing histopathology, mRNA accumulation and C. perfringens colonization by real-time PCR, targeted metabolomics of bile acids, fluorescence in situ hybridization (FISH), or terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Results At the cellular level, birds infected with E. maxima and C. perfringens developed subclinical NE and showed shortening villi, crypt hyperplasia and immune cell infiltration in ileum. Dietary DCA alleviated the NE-induced ileal inflammation in a dose-dependent manner compared to NE control birds. Consistent with the increased histopathological scores, subclinical NE birds suffered body weight gain reduction compared to the uninfected birds, an effect attenuated with increased doses of dietary DCA. At the molecular level, the highest dose of DCA at 1.5 g/kg reduced C. perfringens luminal colonization compared to NE birds using PCR and FISH. Furthermore, the dietary DCA reduced subclinical NE-induced intestinal inflammatory gene expression and cell apoptosis using PCR and TUNEL assays. Upon further examining ileal bile acid pool through targeted metabolomics, subclinical NE reduced the total bile acid level in ileal digesta compared to uninfected birds. Notably, dietary DCA increased total bile acid and DCA levels in a dose-dependent manner compared to NE birds. Conclusion These results indicate that DCA attenuates NE-induced intestinal inflammation and bile acid reduction and could be an effective antimicrobial alternative against the intestinal disease.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Interplay between bile acid metabolism and microbiota in irritable bowel syndrome
    Dior, M.
    Delagreverie, H.
    Duboc, H.
    Jouet, P.
    Coffin, B.
    Brot, L.
    Humbert, L.
    Trugnan, G.
    Seksik, P.
    Sokol, H.
    Rainteau, D.
    Sabate, J. -M.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 28 (09): : 1330 - 1340
  • [22] Profiling gut microbiota and bile acid metabolism in critically ill children
    Iain Robert Louis Kean
    Joseph Wagner
    Anisha Wijeyesekera
    Marcus De Goffau
    Sarah Thurston
    John A. Clark
    Deborah K. White
    Jenna Ridout
    Shruti Agrawal
    Riaz Kayani
    Roddy O’Donnell
    Padmanabhan Ramnarayan
    Mark J. Peters
    Nigel Klein
    Elaine Holmes
    Julian Parkhill
    Stephen Baker
    Nazima Pathan
    Scientific Reports, 12
  • [23] Gallic acid attenuates murine ulcerative colitis by promoting group 3 innate lymphocytes, affecting gut microbiota, and bile acid metabolism
    Leng, Yun
    Zhang, Xiao
    Zhang, Qian
    Xia, Jiaxuan
    Zhang, Yuefeng
    Ma, Chong
    Liu, Kun
    Li, Hao
    Hong, Yanjun
    Xie, Zhiyong
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2024, 131
  • [24] Effects of Bile Acid Modulation by Dietary Fat, Cholecystectomy, and Bile Acid Sequestrant on Energy, Glucose, and Lipid Metabolism and Gut Microbiota in Mice
    Park, Sunmin
    Zhang, Ting
    Yue, Yu
    Wu, Xuangao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [25] METABOLISM AND ENTEROHEPATIC CIRCULATION OF AN IMPORTANT SECONDARY BILE-ACID IN MAN
    FROMM, H
    FARIVAR, S
    CARLSON, GL
    HOFMANN, AF
    AMIN, P
    GASTROENTEROLOGY, 1978, 74 (05) : 1123 - 1123
  • [26] GUT MICROBIOTA CONTRIBUTES TO PROMOTING SECONDARY BILE ACID BIOSYNTHESIS IN NAFLD PATHOGENESIS
    Jiao, Na
    Wu, Dingfeng
    Yang, Zi-Huan
    Fang, Sa
    Li, Xiaoyi
    Yuan, Meifei
    Zhu, Ruixin
    Zhu, Lixin
    GASTROENTEROLOGY, 2019, 156 (06) : S1190 - S1191
  • [27] Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
    Lu, Yifei
    Shao, Mingmei
    Zhang, Caiyun
    Xiang, Hongjiao
    Wang, Junmin
    Wu, Tao
    Ji, Guang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [28] Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
    Vrieze, Anne
    Out, Carolien
    Fuentes, Susana
    Jonker, Lisanne
    Reuling, Isaie
    Kootte, Ruud S.
    van Nood, Els
    Holleman, Frits
    Knaapen, Max
    Romijn, Johannes A.
    Soeters, Maarten R.
    Blaak, Ellen E.
    Dallinga-Thie, Geesje M.
    Reijnders, Dorien
    Ackermans, Mariette T.
    Serlie, Mireille J.
    Knop, Filip K.
    Holst, Jenst J.
    van der Ley, Claude
    Kema, Ido P.
    Zoetendal, Erwin G.
    de Vos, Willem M.
    Hoekstra, Joost B. L.
    Stroes, Erik S.
    Groen, Albert K.
    Nieuwdorp, Max
    JOURNAL OF HEPATOLOGY, 2014, 60 (04) : 824 - 831
  • [29] Interaction of gut microbiota with bile acid metabolism and its influence on disease states
    Christopher Staley
    Alexa R. Weingarden
    Alexander Khoruts
    Michael J. Sadowsky
    Applied Microbiology and Biotechnology, 2017, 101 : 47 - 64
  • [30] Interaction of gut microbiota with bile acid metabolism and its influence on disease states
    Staley, Christopher
    Weingarden, Alexa R.
    Khoruts, Alexander
    Sadowsky, Michael J.
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2017, 101 (01) : 47 - 64